SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,471,273 | -33.7% | 20,517 | -37.5% | 0.00% | -33.3% |
| Q2 2023 | $3,727,806 | -33.7% | 32,847 | -19.5% | 0.01% | -33.3% |
| Q1 2023 | $5,620,983 | -3.6% | 40,782 | -9.3% | 0.01% | -10.0% |
| Q4 2022 | $5,828,120 | +28.1% | 44,977 | +9.3% | 0.01% | +25.0% |
| Q3 2022 | $4,548,000 | +1518.5% | 41,146 | +996.3% | 0.01% | – |
| Q2 2022 | $281,000 | -75.6% | 3,753 | -44.4% | 0.00% | -100.0% |
| Q4 2020 | $1,152,000 | -15.9% | 6,755 | -30.7% | 0.00% | -33.3% |
| Q3 2020 | $1,369,000 | -42.2% | 9,751 | -34.0% | 0.00% | -50.0% |
| Q2 2020 | $2,368,000 | +725.1% | 14,769 | +512.3% | 0.01% | +500.0% |
| Q1 2019 | $287,000 | -36.1% | 2,412 | -41.4% | 0.00% | 0.0% |
| Q4 2018 | $449,000 | -21.8% | 4,115 | +15.8% | 0.00% | 0.0% |
| Q3 2018 | $574,000 | – | 3,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |